Results 231 to 240 of about 1,276,365 (260)

Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels.

Journal of Molecular Biology, 1996
B. Miroux, J. Walker
semanticscholar   +1 more source

The population genetics of pathogenic Escherichia coli

Nature Reviews Microbiology, 2020
Erick Denamur, Olivier Clermont, David M Gordon   +2 more
exaly  

Light-driven CO2 sequestration in Escherichia coli to achieve theoretical yield of chemicals

Nature Catalysis, 2021
Guipeng Hu, Chao Ye, Cong Gao
exaly  

Production of Disulfide‐Bonded Proteins in Escherichia coli

Current Protocols in Molecular Biology, 2014
N. Ke, M. Berkmen
semanticscholar   +1 more source

Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli

Nature, 2020
Cayetano Pleguezuelos-Manzano, Jens Puschhof, Axel Rosendahl Huber   +2 more
exaly  

Structure and energetics of ligand binding to proteins: Escherichia coli dihydrofolate reductase‐trimethoprim, a drug‐receptor system

Proteins: Structure, Function, and Bioinformatics, 1988
P. Dauber-Osguthorpe, V. Roberts, D. Osguthorpe, Jon Wolff, Moniqe Genest, A. Hagler   +5 more
semanticscholar   +1 more source

Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase.

Analytical Biochemistry, 1991
K. Guan, J. Dixon
semanticscholar   +1 more source

Pathogenic Escherichia coli

Nature Reviews Microbiology, 2004
James B Kaper, Harry L T Mobley
exaly  

The population genetics of commensal Escherichia coli

Nature Reviews Microbiology, 2010
Olivier Tenaillon, David Skurnik, Erick Denamur   +2 more
exaly  

Recombinant Protein Expression in Escherichia coli (E.coli): What We Need to Know.

Current pharmaceutical design, 2018
S. M. Hayat, Najmeh Farahani, Behrouz Golichenari, A. Sahebkar   +3 more
semanticscholar   +1 more source